RESEARCH PROJECTS 2018-2021 SA262P18 (Q6916338)

From EU Knowledge Graph
Jump to navigation Jump to search
Project 2018/000003-J07600394310 in Spain
Language Label Description Also known as
English
RESEARCH PROJECTS 2018-2021 SA262P18
Project 2018/000003-J07600394310 in Spain

    Statements

    0 references
    60,000.0 Euro
    0 references
    120,000.0 Euro
    0 references
    50.0 percent
    0 references
    23 November 2018
    0 references
    31 October 2021
    0 references
    UNIVERSIDAD DE SALAMANCA
    0 references

    40°57'6.77"N, 5°40'43.54"W
    0 references
    37008
    0 references
    PROYECTOS INVESTIGACIÓN 2018-2021 USAL_x000D_ COMBINACIÓN DE NUEVOS AGENTES ANTITUBULINA Y ANÁLOGOS ALQUILFOSFOLÍPIDOS COMO UNA NUEVA ESTRATEGIA FRENTE A CÁNCER Y LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Spanish)
    0 references
    Výskumné projekty 2018 – 2021 USAL_x000D_ KOMBINÁCIE NOVÝCH antitubulínových AGENTov a alkylfosfolipidových Analógov ako NOVÝ ŠTRATEGY Z KANCELE A LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Slovak)
    0 references
    Ερευνητικά Έργα 2018-2021 USAL_x000D_ COMBINATION OF NEW Antitubulin AGENTS AND Alkylphospholipid Analogs ΩΣ ΝΕΑ ΣΤΡΑΤΗΓΙΚΗ ΑΠΟ ΚΑΡΚΙΝΟ ΚΑΙ LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Greek)
    0 references
    Research Projects 2018-2021 USAL_x000D_ COMBINATION OF NEW Antitubulin AGENTS AND Alkylphospholipid Analogs AS A NEW STRATEGY FROM CANCER AND LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (English)
    0.0606798361663466
    0 references
    Forschungsprojekte 2018-2021 USAL_x000D_ COMBINATION OF NEW Antitubulin AGENTS AND Alkylphospholipid Analogs AS A NEW STRATEGY FROM CANCER AND LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (German)
    0 references
    Progetti di ricerca 2018-2021 USAL_x000D_ COMBINAZIONE DI NUOVI AGENTI antitubulina E Analoghi alchilfosfolipidi COME NUOVA STRATEGIA DA CANCER E LEISHMANIOSIS._x000D_ PELÁEZ LAMIE DE CLAIRAC ARROYO, RAFAEL (Italian)
    0 references
    Výzkumné projekty 2018–2021 USAL_x000D_ COMBINATION OF NEW antitubulin AGENTS and alkylphospholipid Analogs AS A NEW STRATEGY OF CANCER AND LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Czech)
    0 references
    Mokslinių tyrimų projektai 2018–2021 USAL_x000D_ NAUJŲ antitubulino AGENTų ir alkilfosfolipidų Analogai kaip NAUJIENA STRATEGIJA IŠ VALSTYBĖS IR LEISHMANIOSIS._x000D_ PELĮEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Lithuanian)
    0 references
    Onderzoeksprojecten 2018-2021 USAL_x000D_ COMBINATIE VAN NIEUWE antitubulineGENTS EN alkylfosfolipide Analogen als een nieuwe STRATEGIE VAN CANCER EN LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Dutch)
    0 references
    Tionscadail Taighde 2018-2021 USAL_x000D_ COMBINATION OF NUA untitubulin AGENTS AGUS Ailcilfospholipid Analóga MAR AON CANCER NUA AGUS LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Irish)
    0 references
    Raziskovalni projekti 2018–2021 USAL_x000D_ COMBINATION of NEW antitubulin AGENTS AND alkylphospholipid Analogs kot nov STRATEGY FANCER IN LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Slovenian)
    0 references
    Forskningsprojekt 2018–2021 USAL_x000D_ KOMBINATION AV nya antitubulinagener och alkylfosfolipidanaloger som en ny strategi från CANCER OCH LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Swedish)
    0 references
    Projetos de investigação 2018-2021 USAL_x000D_ COMBINAÇÃO DE NOVOS AGENTES de antitubulina e Analógios alquilfosfolípidos como uma nova estratégia de CANCER e LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Portuguese)
    0 references
    Forskningsprojekter 2018-2021 USAL_x000D_ KOMBINATION AF NYE antitubulin AGENTS OG alkylphospholipid Analoger AS A NEW STRATEGY FRA KANCER OG LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Danish)
    0 references
    Pētnieciskie projekti 2018–2021 USAL_x000D_ Jauno antitubulīnu Aģentu un alkilfosfolipīdu analogi AS A NEW STRATEGY FROM CANCER UN LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Latvian)
    0 references
    Научноизследователски проекти 2018—2021 USAL_x000D_ COMBINATION OF NEW Antitubulin AGENTS and alkylphospholipid Analogs AS AW STRATEGY FROM CANCER AND LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Bulgarian)
    0 references
    Tutkimushankkeet 2018–2021 USAL_x000D_ UUSI antitubuliini AGENTS JA alkyylifosfolipidin Analogit UUSI STRATEGIA RANCER JA LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Finnish)
    0 references
    Proiecte de cercetare 2018-2021 USAL_x000D_ COMBINAȚIA NOUA AGENTS antitubulină ȘI Analogii alchilfosfolipide ca o nouă STRATEGIE DIN CANCER ȘI LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Romanian)
    0 references
    Proġetti ta ‘Riċerka 2018–2021 USAL_x000D_ COMBINATION OF NEW antitubulin AĠENTI U Analogi alkylphospholipid bħala ġodda STRATEGY mill CANCER U LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Maltese)
    0 references
    Istraživački projekti 2018 – 2021 USAL_x000D_ COMBINATION OF NEW Antitubulin AGENTS AND alkylphospholipid Analogs Kao NOVI STRATEGIJA od CANCER I LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Croatian)
    0 references
    Uurimisprojektid 2018–2021 USAL_x000D_ Uute tuberkuloosivastaste ravimite ja alküülfosfolipiidide analoogide ÜHENDUSED AS UUUS STRATEEGIA KASUTAMINE JA LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Estonian)
    0 references
    Projets de recherche 2018-2021 USAL_x000D_ COMBINATION DES NOUVELLES AGENTS D’Antitubuline ET Analoges alkylphospholipides EN NOUVELLE STRATÉGIE DE CANCER ET LEISHMANIOSIS._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (French)
    0 references
    Kutatási projektek 2018–2021 USAL_x000D_ Új antitubulin- és alkil-foszfolipid analógok KÖZLEMÉNYE A CANCER ÉS LEISHMANIOSIS ÚJ STRATÉGIA._x000D_ PELÁEZ LAMAMIE DE CLAIRAC ARROYO, RAFAEL (Hungarian)
    0 references
    21 December 2023
    0 references

    Identifiers

    2018/000003-J07600394310
    0 references